#ovarian cancer

Squelching Ovarian Cancer: The Not-So-Silent Killer

September is Gynecologic Cancer Awareness Month.

September is Ovarian Cancer Awareness Month

The combination of target drugs Tafinlar-Mekinist is approved for nearly any type of advanced solid tumor that has the BRAF gene mutation.

A nutritionist who believes in the power of food and yoga to nourish the mind and body of cancer survivors

Becoming a patient advocate during her mom’s ovarian cancer journey led to her life’s work to improve the cancer experience.

Each 10% increase in state spending decreased racial disparities in five-year overall survival by 5%.

The virtual intervention was deemed appropriate and involved an acceptable time commitment.

Known as a carbon nanotube, the implant can detect cancer-associated proteins and alert a devise outside the body.

As an organization whose mission is to improve cancer care globally, NCCN stands in solidarity with the Ukrainian people.

Clinical testing of this approach in people with ovarian cancer is expected to start later this year.

A vaccine designed to enhance T-cell activity could help CAR-T therapy work better against solid tumors.

A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.

Tragedy may have saved her life.

There are many ways to get smarter in this issue.

New clues help explain why only 10-15% of ovarian cancer patients respond favorably to immune checkpoint inhibitor therapy.

For some people with access to skilled surgeons, surgery plus chemotherapy improves survival compared to chemotherapy alone.